Pagenax®: Robust visual gains and superior anatomical outcomes vs. aflibercept1,2
VA, visual acuity; IRF, intra-retinal fluid; SRF, sub-retinal fluid; RPE, retinal pigment epithelium
The primary efficacy endpoint for the studies was...
VA, visual acuity; IRF, intra-retinal fluid; SRF, sub-retinal fluid; RPE, retinal pigment epithelium
The primary efficacy endpoint for the studies was...